Thomas R. Kreil

Global Pathogen Safety

Austria

About

Years of experience with plasma products, recombinants, vaccines, as well as gene- and cell-therapy / ATMPs

Experience

  • VP - Global Pathogen Safety, Board Member & Executive Director for Austrian Legal Entity at Takeda
    Jan 2019 - Present · 7 yrs 7 mos

  • Shire ()
    • Vice President Global Pathogen Safety
      Jul 2018 - Jan 2019 · 7 mos

    • Senior Director Global Pathogen Safety
      Jul 2016 - Jun 2018 · 2 yrs

  • Senior Director Global Pathogen Safety at Baxalta
    Jul 2015 - Jun 2016 · 1 yr

  • Baxter BioScience (15 yrs 6 mos)
    • Senior Director Viral Vaccines & Global Pathogen Safety
      Sep 2008 - Jun 2015 · 6 yrs 10 mos

      Provide direction for a group of in total >100 scientists, in the areas of virus vaccine development and pathogen safety of biological medicinal products.

    • Director Global Pathogen Safety
      Jan 2000 - Sep 2008 · 8 yrs 9 mos

      After the Baxter - Immuno take-over, established a purpose-built BSL-3 laboratory complex in Vienna/Austria and reconciled the Viral Safety / Pathogen Safety functions of both companiers from their original Los Angeles/US & Orth/Austria locations into the new Vienna facility. Developed the group to a size of approx. 40; the group now enjoys a world-class reputation in the field.